Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07133971

A Clinical Observational Study Evaluating the Efficacy of Cerave Neuroceramide Intensive Repair Body Lotion .

A Clinical Observational Study Evaluating the Efficacy of Cerave Neuroceramide Intensive Repair Body Lotion in Improving Dry Skin in the Elderly

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
210 (estimated)
Sponsor
ChinaNorm · Industry
Sex
All
Age
55 Years
Healthy volunteers

Summary

This study is a single-center observational clinical study aimed at evaluating the impact of Cerave Neuroceramide Moisturizing Repair Body Lotion on the quality of life, improvement in skin condition, and satisfaction with the product experience among individuals with moderate to severe dry skin associated with aging. The study plans to recruit approximately 210 male or female participants aged 55 years or older with moderate to severe skin dryness in the affected areas (accounting for a dropout rate and protocol violation rate of no more than 5%), and will screen participants based on inclusion and exclusion criteria to ensure that at least 200 participants complete the study. Participants entering this study will be categorized based on ODS and NRS scores into: moderate or severe skin dryness (moderate-grade 2, severe-grade 3), with the sample size ratio between moderate and severe groups maintained at 1:1. This study will last for 4 weeks and include 2 visits. Visits will be conducted at baseline (T0) and week 4 (T4w). The window period for the week 4 (T4w) visit is ±2 days. This study does not involve randomization. All study participants will use Cerave Neuroceramide Moisturizing Repair Body Lotion on areas of skin dryness.

Conditions

Interventions

TypeNameDescription
OTHERskin care product(Cerave Neuroceramide Moisturizing Repair Body Lotion)All study participants will use Cerave Neuroceramide Moisturizing Body Lotion during the trial period, applying it every night to dry skin areas. If topical medications are used, they should be applied first to dry skin areas, followed by the product.

Timeline

Start date
2025-08-22
Primary completion
2025-11-01
Completion
2026-01-01
First posted
2025-08-21
Last updated
2025-08-21

Source: ClinicalTrials.gov record NCT07133971. Inclusion in this directory is not an endorsement.